DK2364366T3 - Affoldningsmetode - Google Patents

Affoldningsmetode

Info

Publication number
DK2364366T3
DK2364366T3 DK09752326.0T DK09752326T DK2364366T3 DK 2364366 T3 DK2364366 T3 DK 2364366T3 DK 09752326 T DK09752326 T DK 09752326T DK 2364366 T3 DK2364366 T3 DK 2364366T3
Authority
DK
Denmark
Prior art keywords
folding method
folding
Prior art date
Application number
DK09752326.0T
Other languages
English (en)
Inventor
Markus Enzelberger
Original Assignee
Morphosys Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphosys Ag filed Critical Morphosys Ag
Application granted granted Critical
Publication of DK2364366T3 publication Critical patent/DK2364366T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK09752326.0T 2008-11-05 2009-11-04 Affoldningsmetode DK2364366T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11151008P 2008-11-05 2008-11-05
US15081709P 2009-02-09 2009-02-09
PCT/EP2009/064625 WO2010052244A1 (en) 2008-11-05 2009-11-04 Deconvolution method

Publications (1)

Publication Number Publication Date
DK2364366T3 true DK2364366T3 (da) 2014-03-31

Family

ID=41664806

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09752326.0T DK2364366T3 (da) 2008-11-05 2009-11-04 Affoldningsmetode

Country Status (4)

Country Link
US (1) US9267952B2 (da)
EP (1) EP2364366B1 (da)
DK (1) DK2364366T3 (da)
WO (1) WO2010052244A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2364366B1 (en) 2008-11-05 2014-01-08 MorphoSys AG Deconvolution method

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05505823A (ja) 1990-03-27 1993-08-26 ザ・ソーク・インスティチュート・フォー・バイオロジカル・スタディーズ 細胞成長抑制法およびそれに有用な組成物
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
SE9401650D0 (sv) 1994-05-11 1994-05-11 Lars Frykberg Nytt sätt att identifiera peptider samt hjälpmedel som kan användas vid sättet
US20030100007A1 (en) 1995-12-18 2003-05-29 Howard Benjamin Methods for identifying compounds that bind to a target
ATE203545T1 (de) 1996-04-24 2001-08-15 Medivir Uk Ltd Substrate und inhibitoren von proteolytischen enzymen
US6541011B2 (en) * 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
CA2378573A1 (en) 1999-07-05 2001-01-11 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method for high-throughput selection of binding partners
DE19936563A1 (de) 1999-08-04 2001-02-08 Boehringer Ingelheim Int Tumorassoziiertes Antigen
US6794132B2 (en) 1999-10-02 2004-09-21 Biosite, Inc. Human antibodies
JP5424640B2 (ja) 2005-09-08 2014-02-26 ザ ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン，インコーポレイティド 免疫源性ペプチドの標的特異的同定方法
EP2364366B1 (en) 2008-11-05 2014-01-08 MorphoSys AG Deconvolution method

Also Published As

Publication number Publication date
WO2010052244A1 (en) 2010-05-14
US20110200589A1 (en) 2011-08-18
US9267952B2 (en) 2016-02-23
EP2364366B1 (en) 2014-01-08
EP2364366A1 (en) 2011-09-14

Similar Documents

Publication Publication Date Title
BRPI0919116A2 (pt) método
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
DK2370462T3 (da) Glucagon-analoger
BRPI0907376A2 (pt) Fotobiorretador
DK2342317T3 (da) Hængende-dråbe-plade
DE602009000234D1 (de) msignals
DK2308877T3 (da) Imidazopyridin-2-on-derivater
BRPI0914649A2 (pt) Piprazolo-quinazolinas
DE602008003972D1 (de) Sitzrücklehnungsmechanismus
DK2313489T3 (da) Fremstillingsmetode
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
DK2336132T3 (da) Morpholinpurinderivat
DK2342454T3 (da) Vindkraftanlæg
DK2335031T3 (da) In-line-måler
DK2275414T3 (da) Cyclopentylacrylamidderivat
DK2379557T3 (da) Aminopyrazol-forbindelse
DE602008003970D1 (de) Strahlstromkalibriersystem
BRPI0911625A2 (pt) Métodos
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
BRPI0907522A2 (pt) biarlamidas
ATE534634T1 (de) 2-phenyl-4-cyclopropyl-pyrimidinderivate
BRPI0909634A2 (pt) 2-aminoquinolinas
DE112009001946A5 (de) Mobelauszugsführung